nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—muscle cancer	0.657	1	CbGaD
Etodolac—PTGS2—Etoposide—muscle cancer	0.0656	0.364	CbGbCtD
Etodolac—PTGS1—Etoposide—muscle cancer	0.0554	0.307	CbGbCtD
Etodolac—SLC22A6—Methotrexate—muscle cancer	0.0321	0.178	CbGbCtD
Etodolac—ALB—Methotrexate—muscle cancer	0.0273	0.152	CbGbCtD
Etodolac—UGT1A10—renal system—muscle cancer	0.00165	0.168	CbGeAlD
Etodolac—RXRA—renal system—muscle cancer	0.000985	0.1	CbGeAlD
Etodolac—PTGS2—hindlimb—muscle cancer	0.000967	0.0983	CbGeAlD
Etodolac—PTGS2—appendage—muscle cancer	0.000829	0.0843	CbGeAlD
Etodolac—UGT1A9—renal system—muscle cancer	0.000829	0.0843	CbGeAlD
Etodolac—UGT2B7—renal system—muscle cancer	0.000669	0.068	CbGeAlD
Etodolac—RXRA—head—muscle cancer	0.000659	0.067	CbGeAlD
Etodolac—UGT2B7—testis—muscle cancer	0.000432	0.0439	CbGeAlD
Etodolac—Anaphylactic shock—Vincristine—muscle cancer	0.0004	0.00262	CcSEcCtD
Etodolac—Oedema—Vincristine—muscle cancer	0.0004	0.00262	CcSEcCtD
Etodolac—Infection—Vincristine—muscle cancer	0.000397	0.0026	CcSEcCtD
Etodolac—Thrombocytopenia—Vincristine—muscle cancer	0.000391	0.00256	CcSEcCtD
Etodolac—Photosensitivity—Doxorubicin—muscle cancer	0.000389	0.00255	CcSEcCtD
Etodolac—Decreased appetite—Dactinomycin—muscle cancer	0.000389	0.00255	CcSEcCtD
Etodolac—Dysgeusia—Etoposide—muscle cancer	0.000388	0.00254	CcSEcCtD
Etodolac—Hyperhidrosis—Vincristine—muscle cancer	0.000386	0.00253	CcSEcCtD
Etodolac—Fatigue—Dactinomycin—muscle cancer	0.000386	0.00253	CcSEcCtD
Etodolac—Pain—Dactinomycin—muscle cancer	0.000383	0.00251	CcSEcCtD
Etodolac—Vascular purpura—Doxorubicin—muscle cancer	0.000382	0.0025	CcSEcCtD
Etodolac—Anorexia—Vincristine—muscle cancer	0.000381	0.00249	CcSEcCtD
Etodolac—Hepatic failure—Doxorubicin—muscle cancer	0.00038	0.00249	CcSEcCtD
Etodolac—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000377	0.00247	CcSEcCtD
Etodolac—Irritability—Methotrexate—muscle cancer	0.000377	0.00247	CcSEcCtD
Etodolac—Hypotension—Vincristine—muscle cancer	0.000373	0.00245	CcSEcCtD
Etodolac—Feeling abnormal—Dactinomycin—muscle cancer	0.000369	0.00241	CcSEcCtD
Etodolac—Ill-defined disorder—Etoposide—muscle cancer	0.000368	0.00241	CcSEcCtD
Etodolac—Anaemia—Etoposide—muscle cancer	0.000367	0.0024	CcSEcCtD
Etodolac—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000366	0.0024	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000364	0.00238	CcSEcCtD
Etodolac—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000362	0.00237	CcSEcCtD
Etodolac—Insomnia—Vincristine—muscle cancer	0.000361	0.00237	CcSEcCtD
Etodolac—Renal impairment—Doxorubicin—muscle cancer	0.000359	0.00235	CcSEcCtD
Etodolac—Paraesthesia—Vincristine—muscle cancer	0.000359	0.00235	CcSEcCtD
Etodolac—Malaise—Etoposide—muscle cancer	0.000358	0.00234	CcSEcCtD
Etodolac—Dermatitis bullous—Doxorubicin—muscle cancer	0.000357	0.00234	CcSEcCtD
Etodolac—Vertigo—Etoposide—muscle cancer	0.000356	0.00233	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000355	0.00233	CcSEcCtD
Etodolac—Leukopenia—Etoposide—muscle cancer	0.000355	0.00233	CcSEcCtD
Etodolac—Purpura—Doxorubicin—muscle cancer	0.000354	0.00232	CcSEcCtD
Etodolac—Abdominal pain—Dactinomycin—muscle cancer	0.000354	0.00232	CcSEcCtD
Etodolac—Body temperature increased—Dactinomycin—muscle cancer	0.000354	0.00232	CcSEcCtD
Etodolac—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000353	0.00231	CcSEcCtD
Etodolac—Loss of consciousness—Etoposide—muscle cancer	0.000349	0.00228	CcSEcCtD
Etodolac—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000349	0.00228	CcSEcCtD
Etodolac—Decreased appetite—Vincristine—muscle cancer	0.000347	0.00228	CcSEcCtD
Etodolac—Fatigue—Vincristine—muscle cancer	0.000345	0.00226	CcSEcCtD
Etodolac—Convulsion—Etoposide—muscle cancer	0.000344	0.00225	CcSEcCtD
Etodolac—Hypertension—Etoposide—muscle cancer	0.000342	0.00224	CcSEcCtD
Etodolac—Pain—Vincristine—muscle cancer	0.000342	0.00224	CcSEcCtD
Etodolac—Constipation—Vincristine—muscle cancer	0.000342	0.00224	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000342	0.00224	CcSEcCtD
Etodolac—Asthma—Methotrexate—muscle cancer	0.000341	0.00223	CcSEcCtD
Etodolac—Eosinophilia—Methotrexate—muscle cancer	0.000338	0.00221	CcSEcCtD
Etodolac—Pancreatitis—Methotrexate—muscle cancer	0.000334	0.00219	CcSEcCtD
Etodolac—Discomfort—Etoposide—muscle cancer	0.000334	0.00219	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—muscle cancer	0.00033	0.00216	CcSEcCtD
Etodolac—Abdominal discomfort—Methotrexate—muscle cancer	0.000327	0.00214	CcSEcCtD
Etodolac—Gastrointestinal pain—Vincristine—muscle cancer	0.000327	0.00214	CcSEcCtD
Etodolac—Confusional state—Etoposide—muscle cancer	0.000326	0.00214	CcSEcCtD
Etodolac—Pancytopenia—Methotrexate—muscle cancer	0.000324	0.00212	CcSEcCtD
Etodolac—Anaphylactic shock—Etoposide—muscle cancer	0.000324	0.00212	CcSEcCtD
Etodolac—Infection—Etoposide—muscle cancer	0.000322	0.00211	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—muscle cancer	0.000321	0.0021	CcSEcCtD
Etodolac—Neutropenia—Methotrexate—muscle cancer	0.000319	0.00209	CcSEcCtD
Etodolac—Dysuria—Methotrexate—muscle cancer	0.000319	0.00209	CcSEcCtD
Etodolac—Thrombocytopenia—Etoposide—muscle cancer	0.000317	0.00208	CcSEcCtD
Etodolac—Tachycardia—Etoposide—muscle cancer	0.000316	0.00207	CcSEcCtD
Etodolac—Abdominal pain—Vincristine—muscle cancer	0.000316	0.00207	CcSEcCtD
Etodolac—Body temperature increased—Vincristine—muscle cancer	0.000316	0.00207	CcSEcCtD
Etodolac—Hyperhidrosis—Etoposide—muscle cancer	0.000313	0.00205	CcSEcCtD
Etodolac—Abdominal pain upper—Doxorubicin—muscle cancer	0.000312	0.00204	CcSEcCtD
Etodolac—Photosensitivity reaction—Methotrexate—muscle cancer	0.000311	0.00204	CcSEcCtD
Etodolac—Anorexia—Etoposide—muscle cancer	0.000309	0.00202	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000308	0.00201	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—muscle cancer	0.000306	0.002	CcSEcCtD
Etodolac—Pneumonia—Methotrexate—muscle cancer	0.000306	0.002	CcSEcCtD
Etodolac—Hypotension—Etoposide—muscle cancer	0.000303	0.00198	CcSEcCtD
Etodolac—Gastritis—Doxorubicin—muscle cancer	0.000302	0.00198	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000301	0.00197	CcSEcCtD
Etodolac—Renal failure—Methotrexate—muscle cancer	0.000299	0.00196	CcSEcCtD
Etodolac—Abdominal distension—Doxorubicin—muscle cancer	0.000297	0.00195	CcSEcCtD
Etodolac—Stomatitis—Methotrexate—muscle cancer	0.000296	0.00194	CcSEcCtD
Etodolac—Conjunctivitis—Methotrexate—muscle cancer	0.000296	0.00194	CcSEcCtD
Etodolac—Asthma—Doxorubicin—muscle cancer	0.000295	0.00193	CcSEcCtD
Etodolac—Hypersensitivity—Vincristine—muscle cancer	0.000294	0.00193	CcSEcCtD
Etodolac—Eosinophilia—Doxorubicin—muscle cancer	0.000292	0.00191	CcSEcCtD
Etodolac—Sweating—Methotrexate—muscle cancer	0.000291	0.00191	CcSEcCtD
Etodolac—Paraesthesia—Etoposide—muscle cancer	0.000291	0.0019	CcSEcCtD
Etodolac—Haematuria—Methotrexate—muscle cancer	0.00029	0.0019	CcSEcCtD
Etodolac—Pancreatitis—Doxorubicin—muscle cancer	0.00029	0.0019	CcSEcCtD
Etodolac—Dyspnoea—Etoposide—muscle cancer	0.000289	0.00189	CcSEcCtD
Etodolac—Somnolence—Etoposide—muscle cancer	0.000288	0.00188	CcSEcCtD
Etodolac—Asthenia—Vincristine—muscle cancer	0.000287	0.00188	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—muscle cancer	0.000284	0.00186	CcSEcCtD
Etodolac—Bronchitis—Doxorubicin—muscle cancer	0.000284	0.00186	CcSEcCtD
Etodolac—Agranulocytosis—Methotrexate—muscle cancer	0.000284	0.00186	CcSEcCtD
Etodolac—Rash—Dactinomycin—muscle cancer	0.000282	0.00185	CcSEcCtD
Etodolac—Decreased appetite—Etoposide—muscle cancer	0.000281	0.00184	CcSEcCtD
Etodolac—Pancytopenia—Doxorubicin—muscle cancer	0.00028	0.00184	CcSEcCtD
Etodolac—Fatigue—Etoposide—muscle cancer	0.000279	0.00183	CcSEcCtD
Etodolac—Pain—Etoposide—muscle cancer	0.000277	0.00181	CcSEcCtD
Etodolac—Constipation—Etoposide—muscle cancer	0.000277	0.00181	CcSEcCtD
Etodolac—Neutropenia—Doxorubicin—muscle cancer	0.000276	0.00181	CcSEcCtD
Etodolac—Dysuria—Doxorubicin—muscle cancer	0.000276	0.00181	CcSEcCtD
Etodolac—PTGS2—embryo—muscle cancer	0.000275	0.028	CbGeAlD
Etodolac—Haemoglobin—Methotrexate—muscle cancer	0.000274	0.0018	CcSEcCtD
Etodolac—Diarrhoea—Vincristine—muscle cancer	0.000273	0.00179	CcSEcCtD
Etodolac—Haemorrhage—Methotrexate—muscle cancer	0.000273	0.00179	CcSEcCtD
Etodolac—Hepatitis—Methotrexate—muscle cancer	0.000273	0.00179	CcSEcCtD
Etodolac—Pollakiuria—Doxorubicin—muscle cancer	0.000273	0.00179	CcSEcCtD
Etodolac—Pharyngitis—Methotrexate—muscle cancer	0.000271	0.00177	CcSEcCtD
Etodolac—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00027	0.00177	CcSEcCtD
Etodolac—Feeling abnormal—Etoposide—muscle cancer	0.000267	0.00175	CcSEcCtD
Etodolac—Hyperglycaemia—Doxorubicin—muscle cancer	0.000266	0.00174	CcSEcCtD
Etodolac—Nausea—Dactinomycin—muscle cancer	0.000266	0.00174	CcSEcCtD
Etodolac—Pneumonia—Doxorubicin—muscle cancer	0.000265	0.00173	CcSEcCtD
Etodolac—Gastrointestinal pain—Etoposide—muscle cancer	0.000265	0.00173	CcSEcCtD
Etodolac—Dizziness—Vincristine—muscle cancer	0.000264	0.00173	CcSEcCtD
Etodolac—Visual impairment—Methotrexate—muscle cancer	0.000263	0.00172	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000261	0.00171	CcSEcCtD
Etodolac—Renal failure—Doxorubicin—muscle cancer	0.000259	0.00169	CcSEcCtD
Etodolac—Erythema multiforme—Methotrexate—muscle cancer	0.000258	0.00169	CcSEcCtD
Etodolac—Urticaria—Etoposide—muscle cancer	0.000257	0.00168	CcSEcCtD
Etodolac—Stomatitis—Doxorubicin—muscle cancer	0.000257	0.00168	CcSEcCtD
Etodolac—Jaundice—Doxorubicin—muscle cancer	0.000257	0.00168	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—muscle cancer	0.000256	0.00168	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—muscle cancer	0.000256	0.00168	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—muscle cancer	0.000256	0.00168	CcSEcCtD
Etodolac—Tinnitus—Methotrexate—muscle cancer	0.000254	0.00167	CcSEcCtD
Etodolac—Vomiting—Vincristine—muscle cancer	0.000254	0.00166	CcSEcCtD
Etodolac—Sweating—Doxorubicin—muscle cancer	0.000252	0.00165	CcSEcCtD
Etodolac—Rash—Vincristine—muscle cancer	0.000252	0.00165	CcSEcCtD
Etodolac—Dermatitis—Vincristine—muscle cancer	0.000252	0.00165	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—muscle cancer	0.000251	0.00164	CcSEcCtD
Etodolac—Headache—Vincristine—muscle cancer	0.00025	0.00164	CcSEcCtD
Etodolac—ALB—testis—muscle cancer	0.000247	0.0252	CbGeAlD
Etodolac—Sinusitis—Doxorubicin—muscle cancer	0.000247	0.00162	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—muscle cancer	0.000246	0.00161	CcSEcCtD
Etodolac—Chills—Methotrexate—muscle cancer	0.000245	0.0016	CcSEcCtD
Etodolac—Alopecia—Methotrexate—muscle cancer	0.000241	0.00158	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—muscle cancer	0.000239	0.00156	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—muscle cancer	0.000238	0.00156	CcSEcCtD
Etodolac—Nausea—Vincristine—muscle cancer	0.000237	0.00155	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—muscle cancer	0.000237	0.00155	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—muscle cancer	0.000236	0.00155	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—muscle cancer	0.000236	0.00155	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—muscle cancer	0.000235	0.00154	CcSEcCtD
Etodolac—Dysgeusia—Methotrexate—muscle cancer	0.000233	0.00152	CcSEcCtD
Etodolac—Asthenia—Etoposide—muscle cancer	0.000232	0.00152	CcSEcCtD
Etodolac—Pruritus—Etoposide—muscle cancer	0.000229	0.0015	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—muscle cancer	0.000228	0.00149	CcSEcCtD
Etodolac—PTGS1—smooth muscle tissue—muscle cancer	0.000227	0.023	CbGeAlD
Etodolac—Vision blurred—Methotrexate—muscle cancer	0.000224	0.00147	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—muscle cancer	0.000223	0.00146	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—muscle cancer	0.000222	0.00145	CcSEcCtD
Etodolac—Ill-defined disorder—Methotrexate—muscle cancer	0.00022	0.00144	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—muscle cancer	0.00022	0.00144	CcSEcCtD
Etodolac—Anaemia—Methotrexate—muscle cancer	0.00022	0.00144	CcSEcCtD
Etodolac—Flushing—Doxorubicin—muscle cancer	0.000219	0.00144	CcSEcCtD
Etodolac—PTGS1—renal system—muscle cancer	0.000218	0.0222	CbGeAlD
Etodolac—PTGS2—smooth muscle tissue—muscle cancer	0.000217	0.022	CbGeAlD
Etodolac—Malaise—Methotrexate—muscle cancer	0.000214	0.0014	CcSEcCtD
Etodolac—Dizziness—Etoposide—muscle cancer	0.000214	0.0014	CcSEcCtD
Etodolac—Vertigo—Methotrexate—muscle cancer	0.000213	0.0014	CcSEcCtD
Etodolac—Leukopenia—Methotrexate—muscle cancer	0.000213	0.00139	CcSEcCtD
Etodolac—Chills—Doxorubicin—muscle cancer	0.000212	0.00139	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—muscle cancer	0.000211	0.00138	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—muscle cancer	0.000209	0.00137	CcSEcCtD
Etodolac—PTGS2—renal system—muscle cancer	0.000208	0.0212	CbGeAlD
Etodolac—Convulsion—Methotrexate—muscle cancer	0.000206	0.00135	CcSEcCtD
Etodolac—Vomiting—Etoposide—muscle cancer	0.000206	0.00135	CcSEcCtD
Etodolac—Rash—Etoposide—muscle cancer	0.000204	0.00134	CcSEcCtD
Etodolac—Dermatitis—Etoposide—muscle cancer	0.000204	0.00134	CcSEcCtD
Etodolac—Headache—Etoposide—muscle cancer	0.000203	0.00133	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—muscle cancer	0.000203	0.00133	CcSEcCtD
Etodolac—Arthralgia—Methotrexate—muscle cancer	0.000202	0.00132	CcSEcCtD
Etodolac—Myalgia—Methotrexate—muscle cancer	0.000202	0.00132	CcSEcCtD
Etodolac—Tension—Doxorubicin—muscle cancer	0.000202	0.00132	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—muscle cancer	0.000201	0.00132	CcSEcCtD
Etodolac—Discomfort—Methotrexate—muscle cancer	0.0002	0.00131	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—muscle cancer	0.0002	0.00131	CcSEcCtD
Etodolac—Confusional state—Methotrexate—muscle cancer	0.000196	0.00128	CcSEcCtD
Etodolac—PTGS1—cardiac atrium—muscle cancer	0.000195	0.0199	CbGeAlD
Etodolac—Anaphylactic shock—Methotrexate—muscle cancer	0.000194	0.00127	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—muscle cancer	0.000194	0.00127	CcSEcCtD
Etodolac—Infection—Methotrexate—muscle cancer	0.000193	0.00126	CcSEcCtD
Etodolac—Nausea—Etoposide—muscle cancer	0.000192	0.00126	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—muscle cancer	0.000191	0.00125	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—muscle cancer	0.00019	0.00125	CcSEcCtD
Etodolac—Thrombocytopenia—Methotrexate—muscle cancer	0.00019	0.00124	CcSEcCtD
Etodolac—Hyperhidrosis—Methotrexate—muscle cancer	0.000187	0.00123	CcSEcCtD
Etodolac—Malaise—Doxorubicin—muscle cancer	0.000186	0.00122	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—muscle cancer	0.000185	0.00121	CcSEcCtD
Etodolac—Anorexia—Methotrexate—muscle cancer	0.000185	0.00121	CcSEcCtD
Etodolac—Syncope—Doxorubicin—muscle cancer	0.000185	0.00121	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—muscle cancer	0.000184	0.00121	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—muscle cancer	0.000182	0.00119	CcSEcCtD
Etodolac—Hypotension—Methotrexate—muscle cancer	0.000181	0.00119	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—muscle cancer	0.000181	0.00118	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—muscle cancer	0.000178	0.00117	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—muscle cancer	0.000178	0.00116	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000177	0.00116	CcSEcCtD
Etodolac—Insomnia—Methotrexate—muscle cancer	0.000175	0.00115	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—muscle cancer	0.000175	0.00115	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—muscle cancer	0.000175	0.00115	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—muscle cancer	0.000175	0.00114	CcSEcCtD
Etodolac—Paraesthesia—Methotrexate—muscle cancer	0.000174	0.00114	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—muscle cancer	0.000173	0.00113	CcSEcCtD
Etodolac—Dyspnoea—Methotrexate—muscle cancer	0.000173	0.00113	CcSEcCtD
Etodolac—Somnolence—Methotrexate—muscle cancer	0.000172	0.00113	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—muscle cancer	0.000171	0.00112	CcSEcCtD
Etodolac—Dyspepsia—Methotrexate—muscle cancer	0.000171	0.00112	CcSEcCtD
Etodolac—PTGS1—tendon—muscle cancer	0.00017	0.0173	CbGeAlD
Etodolac—Confusional state—Doxorubicin—muscle cancer	0.000169	0.00111	CcSEcCtD
Etodolac—Decreased appetite—Methotrexate—muscle cancer	0.000169	0.0011	CcSEcCtD
Etodolac—Oedema—Doxorubicin—muscle cancer	0.000168	0.0011	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—muscle cancer	0.000168	0.0011	CcSEcCtD
Etodolac—Fatigue—Methotrexate—muscle cancer	0.000167	0.00109	CcSEcCtD
Etodolac—Infection—Doxorubicin—muscle cancer	0.000167	0.00109	CcSEcCtD
Etodolac—Pain—Methotrexate—muscle cancer	0.000166	0.00109	CcSEcCtD
Etodolac—Shock—Doxorubicin—muscle cancer	0.000165	0.00108	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—muscle cancer	0.000164	0.00108	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—muscle cancer	0.000164	0.00107	CcSEcCtD
Etodolac—PTGS2—tendon—muscle cancer	0.000163	0.0165	CbGeAlD
Etodolac—Hyperhidrosis—Doxorubicin—muscle cancer	0.000162	0.00106	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—muscle cancer	0.00016	0.00105	CcSEcCtD
Etodolac—Feeling abnormal—Methotrexate—muscle cancer	0.00016	0.00105	CcSEcCtD
Etodolac—Gastrointestinal pain—Methotrexate—muscle cancer	0.000159	0.00104	CcSEcCtD
Etodolac—PTGS1—vagina—muscle cancer	0.000158	0.0161	CbGeAlD
Etodolac—PTGS2—bone marrow—muscle cancer	0.000158	0.016	CbGeAlD
Etodolac—Hypotension—Doxorubicin—muscle cancer	0.000157	0.00103	CcSEcCtD
Etodolac—Urticaria—Methotrexate—muscle cancer	0.000154	0.00101	CcSEcCtD
Etodolac—Body temperature increased—Methotrexate—muscle cancer	0.000153	0.001	CcSEcCtD
Etodolac—Abdominal pain—Methotrexate—muscle cancer	0.000153	0.001	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000153	0.001	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—muscle cancer	0.000152	0.000995	CcSEcCtD
Etodolac—PTGS2—vagina—muscle cancer	0.000151	0.0154	CbGeAlD
Etodolac—Paraesthesia—Doxorubicin—muscle cancer	0.000151	0.000987	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—muscle cancer	0.00015	0.00098	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—muscle cancer	0.000149	0.000978	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—muscle cancer	0.000148	0.000968	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—muscle cancer	0.000146	0.000956	CcSEcCtD
Etodolac—PTGS1—head—muscle cancer	0.000146	0.0148	CbGeAlD
Etodolac—Fatigue—Doxorubicin—muscle cancer	0.000145	0.000948	CcSEcCtD
Etodolac—Pain—Doxorubicin—muscle cancer	0.000144	0.00094	CcSEcCtD
Etodolac—Constipation—Doxorubicin—muscle cancer	0.000144	0.00094	CcSEcCtD
Etodolac—Hypersensitivity—Methotrexate—muscle cancer	0.000143	0.000936	CcSEcCtD
Etodolac—PTGS1—testis—muscle cancer	0.000141	0.0143	CbGeAlD
Etodolac—PTGS2—head—muscle cancer	0.000139	0.0142	CbGeAlD
Etodolac—Asthenia—Methotrexate—muscle cancer	0.000139	0.000911	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—muscle cancer	0.000138	0.000906	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000137	0.000899	CcSEcCtD
Etodolac—Pruritus—Methotrexate—muscle cancer	0.000137	0.000899	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—muscle cancer	0.000133	0.000874	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—muscle cancer	0.000133	0.000869	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—muscle cancer	0.000133	0.000869	CcSEcCtD
Etodolac—Diarrhoea—Methotrexate—muscle cancer	0.000133	0.000869	CcSEcCtD
Etodolac—Dizziness—Methotrexate—muscle cancer	0.000128	0.00084	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—muscle cancer	0.000124	0.00081	CcSEcCtD
Etodolac—Vomiting—Methotrexate—muscle cancer	0.000123	0.000807	CcSEcCtD
Etodolac—Rash—Methotrexate—muscle cancer	0.000122	0.000801	CcSEcCtD
Etodolac—Dermatitis—Methotrexate—muscle cancer	0.000122	0.0008	CcSEcCtD
Etodolac—Headache—Methotrexate—muscle cancer	0.000121	0.000796	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—muscle cancer	0.00012	0.000789	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—muscle cancer	0.000119	0.000778	CcSEcCtD
Etodolac—Nausea—Methotrexate—muscle cancer	0.000115	0.000754	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—muscle cancer	0.000115	0.000752	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—muscle cancer	0.000111	0.000727	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—muscle cancer	0.000107	0.000699	CcSEcCtD
Etodolac—Rash—Doxorubicin—muscle cancer	0.000106	0.000693	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—muscle cancer	0.000106	0.000693	CcSEcCtD
Etodolac—Headache—Doxorubicin—muscle cancer	0.000105	0.000689	CcSEcCtD
Etodolac—Nausea—Doxorubicin—muscle cancer	9.97e-05	0.000653	CcSEcCtD
